Danhua Chemical Technology Co.,Ltd (SHA:600844)
China · Delayed Price · Currency is CNY 3.400
-0.120 (-3.41%)
May 19, 2026, 3:00 PM CST
SHA:600844 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 814.91 | 826.1 | 762.82 | 855.91 | 926.52 | 1,087 |
Other Revenue | - | - | 7.1 | 5.16 | 7.3 | - |
| 814.91 | 826.1 | 769.92 | 861.08 | 933.82 | 1,087 | |
Revenue Growth (YoY) | 1.10% | 7.30% | -10.59% | -7.79% | -14.13% | 1.12% |
Cost of Revenue | 811.96 | 851.66 | 954.73 | 1,091 | 920.7 | 967.91 |
Gross Profit | 2.95 | -25.56 | -184.81 | -230.27 | 13.12 | 119.58 |
Selling, General & Admin | 87.84 | 92.61 | 108.92 | 109.16 | 121.07 | 134.12 |
Research & Development | - | 0.24 | 2.16 | 32.47 | 47.32 | 47.27 |
Other Operating Expenses | 13.42 | 13.26 | 16.6 | 17.79 | 21.02 | 24.66 |
Operating Expenses | 101.26 | 106.11 | 134.07 | 169.63 | 194.49 | 238.19 |
Operating Income | -98.31 | -131.68 | -318.88 | -399.91 | -181.37 | -118.61 |
Interest Expense | - | - | -22.68 | -10.79 | -13.06 | -16.24 |
Interest & Investment Income | - | - | 3.25 | 0.1 | 0.3 | 0.5 |
Currency Exchange Gain (Loss) | - | - | -0 | -0.01 | -0.01 | -0 |
Other Non Operating Income (Expenses) | -23.42 | -23.57 | -14.91 | 0.21 | 0.21 | -0.48 |
EBT Excluding Unusual Items | -121.73 | -155.25 | -353.23 | -410.39 | -193.93 | -134.85 |
Gain (Loss) on Sale of Investments | -2.31 | -2.31 | - | -19.01 | -8.39 | -15.79 |
Gain (Loss) on Sale of Assets | 0.01 | 0.07 | -11.02 | 0.22 | 0.61 | 3.46 |
Asset Writedown | -55.3 | -54.85 | - | -71.04 | -27.96 | - |
Other Unusual Items | - | - | 3.69 | 5.31 | 5.16 | -2.24 |
Pretax Income | -179.33 | -212.33 | -360.56 | -494.91 | -224.51 | -149.42 |
Income Tax Expense | -0.05 | 0.1 | 33.04 | 8.51 | 153.46 | -23.16 |
Earnings From Continuing Operations | -179.28 | -212.43 | -393.6 | -503.42 | -377.97 | -126.26 |
Minority Interest in Earnings | 35.16 | 43.03 | 86.09 | 110.47 | 84.99 | 22.19 |
Net Income | -144.11 | -169.4 | -307.51 | -392.95 | -292.98 | -104.07 |
Net Income to Common | -144.11 | -169.4 | -307.51 | -392.95 | -292.98 | -104.07 |
Shares Outstanding (Basic) | 1,016 | 1,017 | 1,017 | 1,016 | 1,017 | 1,016 |
Shares Outstanding (Diluted) | 1,016 | 1,017 | 1,017 | 1,016 | 1,017 | 1,016 |
Shares Change (YoY) | -0.14% | 0.02% | 0.01% | -0.02% | 0.03% | -0.02% |
EPS (Basic) | -0.14 | -0.17 | -0.30 | -0.39 | -0.29 | -0.10 |
EPS (Diluted) | -0.14 | -0.17 | -0.30 | -0.39 | -0.29 | -0.10 |
Free Cash Flow | -128.44 | -114.66 | -79.74 | -106.73 | -51.56 | 120.74 |
Free Cash Flow Per Share | -0.13 | -0.11 | -0.08 | -0.10 | -0.05 | 0.12 |
Gross Margin | 0.36% | -3.09% | -24.00% | -26.74% | 1.41% | 11.00% |
Operating Margin | -12.06% | -15.94% | -41.42% | -46.44% | -19.42% | -10.91% |
Profit Margin | -17.69% | -20.51% | -39.94% | -45.63% | -31.37% | -9.57% |
Free Cash Flow Margin | -15.76% | -13.88% | -10.36% | -12.39% | -5.52% | 11.10% |
EBITDA | 18.47 | -2.33 | -139.24 | -213.04 | 8.69 | 91.53 |
EBITDA Margin | 2.27% | -0.28% | -18.09% | -24.74% | 0.93% | 8.42% |
D&A For EBITDA | 116.78 | 129.35 | 179.64 | 186.87 | 190.06 | 210.15 |
EBIT | -98.31 | -131.68 | -318.88 | -399.91 | -181.37 | -118.61 |
EBIT Margin | -12.06% | -15.94% | -41.42% | -46.44% | -19.42% | -10.91% |
Revenue as Reported | - | - | 769.92 | 861.08 | 933.82 | 1,087 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.